Webinar goals

Together with the US and the EU, the Japanese biotechnology market is one of the largest and most dynamic in the world. October, in particular, is an interesting month: In just one week the Osaka Partnering Event and Bio Japan take place, which can be seen as the 2 main gateways for European biotechnology in Japan with over 1,400 companies participating in both events.

But doing business in Japan can be a challenge in many ways. That’s why the European alliance of cluster bioXclusters is pleased to invite you to participate in its upcoming webinar focused on this topic.

After useful reminders on the corporate culture and the Japanese market, we will focus on the successful European biotechnology business case on the Japanese market. The webinar will be in English.

Webinar program

• Doing business in Japan: Fabrizio Mura, EU-Japan Centre and Stefan Sandström, BioSector
  • Life Sciences Sector in Japan
  • Challenges and good practices for the success of European SMEs
• Biotech shared experiences: Raul Insa, CEO of SOM Biotech, Nico Foraz, CEO of CTI Biotech, Thomas Bruckdorfer, CSO and VP Business Development, Iris Biotech

Register